Price
$2.74
Change
-$0.02 (-0.72%)
Updated
Jun 2, 6:59 PM EST
GET INTRADAY SIGNALS
68 days until earnings call
Price
$7.86
Change
+$0.02 (+0.26%)
Updated
Jun 2, 6:59 PM EST
GET INTRADAY SIGNALS
60 days until earnings call

AEZS vs INMB ᐉ Comparison: Which is Better to Invest?

Header iconAEZS vs INMB Comparison
Open Charts AEZS vs INMBBanner chart's image
Aeterna Zentaris
Price$2.74
Change-$0.02 (-0.72%)
Volume$25.64K
CapitalizationN/A
GET INTRADAY SIGNALS
INmune Bio
Price$7.86
Change+$0.02 (+0.26%)
Volume$22.42K
CapitalizationN/A
GET INTRADAY SIGNALS
View a ticker or compare two or three
AEZS vs INMB Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AEZS vs. INMB commentary
Jun 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEZS is a Hold and INMB is a StrongBuy.

COMPARISON
Comparison
Jun 03, 2023
Stock price -- (AEZS: $2.75 vs. INMB: $7.86)
Brand notoriety: AEZS and INMB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AEZS: 373% vs. INMB: 88%
Market capitalization -- AEZS: $13.1M vs. INMB: $141.06M
AEZS [@Biotechnology] is valued at $13.1M. INMB’s [@Biotechnology] market capitalization is $141.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $353.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEZS’s FA Score shows that 0 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • AEZS’s FA Score: 0 green, 5 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, INMB is a better buy in the long-term than AEZS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEZS’s TA Score shows that 2 TA indicator(s) are bullish while INMB’s TA Score has 6 bullish TA indicator(s).

  • AEZS’s TA Score: 2 bullish, 6 bearish.
  • INMB’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, INMB is a better buy in the short-term than AEZS.

Price Growth

AEZS (@Biotechnology) experienced а -2.16% price change this week, while INMB (@Biotechnology) price change was +3.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.24%. For the same industry, the average monthly price growth was +40.34%, and the average quarterly price growth was +51.56%.

Reported Earning Dates

AEZS is expected to report earnings on Aug 10, 2023.

INMB is expected to report earnings on Aug 02, 2023.

Industries' Descriptions

@Biotechnology (+2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AEZS with price predictions.
OPEN
A.I.dvisor published
a Summary for INMB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
INMB($141M) has a higher market cap than AEZS($13.1M). INMB YTD gains are higher at: 23.975 vs. AEZS (-13.547). AEZS has higher annual earnings (EBITDA): -23.98M vs. INMB (-25.9M). INMB has more cash in the bank: 51M vs. AEZS (46.6M). AEZS has less debt than INMB: AEZS (210K) vs INMB (15.4M). AEZS has higher revenues than INMB: AEZS (6.25M) vs INMB (249K).
AEZSINMBAEZS / INMB
Capitalization13.1M141M9%
EBITDA-23.98M-25.9M93%
Gain YTD-13.54723.975-57%
P/E RatioN/AN/A-
Revenue6.25M249K2,510%
Total Cash46.6M51M91%
Total Debt210K15.4M1%
FUNDAMENTALS RATINGS
AEZS: Fundamental Ratings
AEZS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AEZSINMB
RSI
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGQX20.570.40
+1.98%
Invesco Growth and Income R5
BVPIX19.030.35
+1.87%
Baywood ValuePlus Institutional
NRIQX12.060.10
+0.84%
Neuberger Berman International Eq R6
GRETX10.62N/A
N/A
Goldman Sachs Real Estate Securities Inv
GMAPX22.77N/A
N/A
Goldman Sachs Small Cap Eq Insghts P

AEZS and

Correlation & Price change

A.I.dvisor tells us that AEZS and CMRX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEZS and CMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEZS
1D Price
Change %
AEZS100%
-1.11%
CMRX - AEZS
31%
Poorly correlated
+4.32%
ENVB - AEZS
30%
Poorly correlated
-11.04%
CUE - AEZS
29%
Poorly correlated
+1.23%
AADI - AEZS
27%
Poorly correlated
+2.03%
FATE - AEZS
27%
Poorly correlated
+3.55%
More

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+0.26%
MDGL - INMB
41%
Loosely correlated
-3.38%
NTLA - INMB
40%
Loosely correlated
+7.34%
DNA - INMB
39%
Loosely correlated
-3.57%
CRSP - INMB
39%
Loosely correlated
+0.74%
ORMP - INMB
38%
Loosely correlated
-2.90%
More